Investment Rating - The report maintains an "Outperform" rating for the pharmaceutical and biotechnology sector [5] Core Views - The overall performance of the pharmaceutical sector has been weaker than the broader market, with the medical services sector experiencing significant declines [1] - The U.S. medical device market in 2025 is expected to be driven by high-end innovative devices, while traditional mature businesses are showing mixed results [2] - The outlook for the Chinese market is cautious in the short term but optimistic in the long term, with specific segments like electrophysiology and diabetes management expected to perform well [2] Summary by Sections Market Performance - The overall A-share market declined by 0.24%, while the biotechnology sector fell by 0.22%, indicating a stronger performance relative to the overall market [1] - The medical device sector showed a slight increase of 0.60% [1] Key Company Earnings Forecasts and Investment Ratings - Major companies such as Mindray Medical, United Imaging, and WuXi AppTec are rated as "Outperform" with projected earnings growth for 2024 to 2027 [4] - For instance, Mindray Medical is expected to have a net profit of 116.7 billion CNY in 2024, with a PE ratio of 19.3x [4] Recommended Stocks - Mindray Medical is highlighted for its strong R&D and sales capabilities, benefiting from domestic medical infrastructure and international expansion [43] - WuXi AppTec is noted for its comprehensive drug development services, poised to benefit from the global outsourcing market [43] - Aier Eye Hospital is recognized as the largest eye care institution in China, leveraging its expertise for growth [43]

证券研究报告 | 2026年03月16日 2026年03月17日 风险提示：研发失败风险；商业化不及预期风险；地缘政治风险；政策 超预期风险。 重点公司盈利预测及投资评级 | 公司 | 公司 | 投资 | 总市值 | | | 归母净利润（亿元） | | | PE | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 代码 | 名称 | 评级 | (亿元) | 2024A | 2025E | 2026E | 2027E | 2024A | 2025E | 2026E | 2027E | | 300760.SZ | 迈瑞医疗 | 优于大市 | 2,254 | 116.7 | 98.8 | 111.5 | 131.3 | 19.3 | 22.8 | 20.2 | 17.2 | | 688271.SH | 联影医疗 | 优于大市 | 1,077 | 12.6 | 18.9 | 23.7 | 27.7 | 85.4 | 57.1 | 45.4 | 38.9 | | 603259.SH | 药明康德 | 优于大市 ...